XT
ANVS icon

XTX Topco’s Annovis Bio ANVS Stock Holding History

XTX Topco’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.8K Buy
+24,580
New +$67.4K ﹤0.01% 3291
2025
Q4 		– Sell
-28,854
Closed -$59.7K – 3287
2025
Q3 		$59.7K Buy
+28,854
New +$72.1K ﹤0.01% 2136
2025
Q1 		– Sell
-11,653
Closed -$58.6K – 2377
2024
Q4 		$58.6K Buy
+11,653
New +$84.3K ﹤0.01% 1872
2024
Q3 		– Sell
-19,907
Closed -$115K – 2060
2024
Q2 		$115K Buy
+19,907
New +$161K 0.01% 1387

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

XTX Topco's ANVS Position: Q1 2026 in Review

XTX Topco opened a new position in Annovis Bio (ANVS) in Q1 2026: 24,580 shares worth $54.8K. The stake represents ﹤0.01% of the portfolio and ranks #3291 among its holdings. This is a return to the name: XTX Topco previously reported a position in ANVS as recently as Q3 2025.

XTX Topco first reported a position in ANVS in Q2 2024 and has held it in 4 quarters since. The position peaked at $115K in Q2 2024. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • XTX Topco held 24,580 shares of Annovis Bio worth $54.8K as of Q1 2026.
  • Annovis Bio was a new XTX Topco position in Q1 2026.
  • Annovis Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3291 holding.
  • XTX Topco first reported a position in Annovis Bio in Q2 2024 and has held it in 4 quarters since.
  • XTX Topco's Annovis Bio position peaked at $115K in Q2 2024.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.